Mathematical modeling of pdgf-driven glioblastoma reveals optimized radiation dosing schedules

135Citations
Citations of this article
260Readers
Mendeley users who have this article in their library.

Abstract

Glioblastomas (GBMs) are the most common and malignant primary brain tumors and are aggressively treated with surgery, chemotherapy, and radiotherapy. Despite this treatment, recurrence is inevitable and survival has improved minimally over the last 50 years. Recent studies have suggested that GBMs exhibit both heterogeneity and instability of differentiation states and varying sensitivities of these states to radiation. Here, we employed an iterative combined theoretical and experimental strategy that takes into account tumor cellular heterogeneity and dynamically acquired radioresistance to predict the effectiveness of different radiation schedules. Using this model, we identified two delivery schedules predicted to significantly improve efficacy by taking advantage of the dynamic instability of radioresistance. These schedules led to superior survival in mice. Our interdisciplinary approach may also be applicable to other human cancer types treated with radiotherapy and, hence, may lay the foundation for significantly increasing the effectiveness of a mainstay of oncologic therapy. PaperClip © 2014 Elsevier Inc.

Cite

CITATION STYLE

APA

Leder, K., Pitter, K., Laplant, Q., Hambardzumyan, D., Ross, B. D., Chan, T. A., … Michor, F. (2014). Mathematical modeling of pdgf-driven glioblastoma reveals optimized radiation dosing schedules. Cell, 156(3), 603–616. https://doi.org/10.1016/j.cell.2013.12.029

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free